Prediction of Long-Term Survival After Liver Transplantation for Familial Transthyretin Amyloidosis-Reference-Cited by-同舟云学术

Prediction of Long-Term Survival After Liver Transplantation for Familial Transthyretin Amyloidosis

Published:2015-11 Issue:19 Volume:66 Page:2154-2156
ISSN:0735-1097
Container-title:Journal of the American College of Cardiology
language:en
Short-container-title:Journal of the American College of Cardiology

Author:

Algalarrondo Vincent,Antonini Teresa,Théaudin Marie,Ducot Béatrice,Lozeron Pierre,Chemla Denis,Benmalek Anouar,Lacroix Catherine,Azoulay Daniel,Castaing Denis,Cauquil Cécile,Rouzet François,Dinanian Sylvie,Eliahou Ludivine,Le Guludec Dominique,Samuel Didier,Slama Michel S.,Adams David

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference4 articles.

1. Clinical improvement and amyloid regression after liver transplantation in hereditary transthyretin amyloidosis;Holmgren;Lancet,1993

2. Guideline of transthyretin-related hereditary amyloidosis for clinicians;Ando;Orphanet J Rare Dis,2013

3. Ten years of international experience with liver transplantation for familial amyloidotic polyneuropathy: results from the familial amyloidotic polyneuropathy world transplant registry;Herlenius;Transplantation,2004

4. Systemic cardiac amyloidoses: disease profiles and clinical courses of the 3 main types;Rapezzi;Circulation,2009

Cited by 21 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Disease‐Modifying Drugs Extend Survival in Hereditary Transthyretin Amyloid Polyneuropathy;Annals of Neurology;2023-12-23

2. Les thérapies géniques en neurologie;Pratique Neurologique - FMC;2023-12

3. Hereditary transthyretin amyloidosis in the era of RNA interference, antisense oligonucleotide, and CRISPR-Cas9 treatments;Blood;2023-11-09

4. Comparison between tafamidis and liver transplantation as first-line therapy for hereditary transthyretin amyloidosis;Amyloid;2023-02-16

5. Treating hereditary transthyretin amyloidosis: Present & future challenges;Revue Neurologique;2023-01